This forum is for the discussion of anything to do with Prostate Cancer. There are only four rules:
No fundraisers, no commercials (although it is OK to recommend choices of treatment or medical people based on your personal research; invitations to participate in third-party surveys are also acceptable, provided there is no compensation to YANA);
No harvesting e-mail addresses for Spam;
No insults or flaming - be polite and respectful at all times and understand that there may be a variety of points of view, all of which may have some validity;
Opinions are OK, but please provide as much factual evidence as possible for any assertions that you are making
Failure to abide by these simple rules will result in the immediate and permanent suspension of your posting privileges.
Since this is an International Forum, please specify your location in your post.
Has anyone had experience with GVAX? I have a trial near to me that I can take advantage of it. I have mets in the Lymph nodes and the bones. Taxotere (Docetaxel) is one option but the chance of using this GVAX is promising longer survivability.
Bob from Mich
GVAX is in two Phase III trials currently, one for men who are asymptomatic (without pain or strictures) with that being GVAX vs. Docetaxel. Another is for men who are symptomatic and is GVAX + Docetaxel vs. Docetaxel. I believe the nature of these trials is that you do not know which arm you will be randomized to. You have a good chance to receive the GVAX treatment, but not certain. Please check with the trial administer on this. Yes, the Phase II trials ended with 34 of 65 men with an immune response, and those men had significant survival compared to all others. This was GVAX alone, not compared to Taxol, though some may have been switched to Taxol when GVAX failed.
At present the only way to access GVAX is through the trial, though this may be a gamble with the randomizing feature. Best of luck.